… This is a retrospective study involving psoriatic patients in … of patients with chronic Hepatitis
B virus infection (mean ± SD) … are needed to evaluate the effects of DAAs in this clinical setting…

… -severe plaque psoriasis in patients who are candidates for phototherapy or systemic therapy
(… Compared with placebo or etanercept, a tumor necrosis factor (TNF) inhibitor, it effectively …

… A retrospective study of 25 patients with psoriasis and … with ustekinumab showed the safety
of ustekinumab in four … safe treatment option that produces rapid clinical improvement for …

… An Italian retrospective multicenter study collected data on … HBV infection patients with
psoriasis received ustekinumab. … No literature data on their use in the setting of HBV infection …

… Hepatitis B virus and hepatitis C virus infections do not … multicenter study; in particular, liver
biochemistry, cholestasis … cirrhotic patients with severe psoriasis treated with ustekinumab. …

… to initiating immunosuppressive therapy, we test patients for evidence of hepatitis B virus (HBV) …
Although preventive therapy has been best studied in the setting of chemotherapy, we …

… The antitumor necrosis factors (anti-TNFs) currently available … both chronic HBV carriers and
those with hepatitis B surface … worsening of psoriasis was reported with ustekinumab in the …

… (especially reactivation of hepatitis B and C virus [Citation16], … Clinical trials, open label
studies, retrospective studies, case … In summary, ustekinumab may be a choice for GPP patients ( …

… therapy and for those with active psoriatic arthritis, alone or in combination with methotrexate.
HBsAg-positive patients treated with Ustekinumab … retrospective analysis of eight patients …

… Therapy with anti-tumor necrosis factor (TNF)-α agents … Switching from anti-TNF agents to
ustekinumab or secukinumab … a retrospective study, carried out in a routine clinical setting on …